Cytokine Signalling Forum

Professor McInnes presents the monthly podcast reviewing a paper by Professor Ying‐Chou Chen and another paper by Professor Genovese.

Professor McInnes presents the monthly podcast reviewing a paper by Dr Katie Bechman and another paper by Professor Lee YH.

In this edition of Congress Author Podcasts, recorded at ACR 2019, the latest data from the FINCH studies are presented by Professors Taylor, Westhovens and Winthrop, in addition to filgotinib safety data from a phase 2 Psoriatic Arthritis trial, presented by Professor Coates.

In this edition, recorded at ACR 2019, real-world tofacitinib safety data is presented by Professor Kremer and the impact of baricitinib and tofacitinib on pain is analysed by Professors Taylor and Dougados

In this edition experts, including Professor Smolen and Professor McInnes, present the latest data for the recently approved JAK inhibitor, upadacitinib. The presentations include: data from the SELECT trials, safety analyses, switching from TNF inhibitors, and the mode of action of upadacitinib.

Professor Calabrese introduces highlights from Day 4 of ACR 2019

Professor Calabrese introduces highlights from Day 3 of ACR 2019

Professor Calabrese presents highlights from Day 2 of ACR 2019

Professor Kevin Winthrop introduces the key abstracts from Day 1 at ACR 2019

Professor McInnes presents the monthly podcast reviewing a paper by Professor Bruno Fautrel and another paper by Professor Christina Charles-Schoeman.

Prof McInnes presents the monthly podcast reviewing a paper he authored along with colleagues and another paper by Dr Mori Shunsuke.

Professor Nash Interviews Professor Fleischmann from the University of Texas Southwester Medical Center, about his two recently published papers on upadacitinib.

Professor Nash Interviews Professor Leonard Calabrese from the RJ Fasenmyer Center for clinical Immunology, about his paper examining the live zoster vaccine in patients treated with tofacitinib monotherapy, tofacitinib with MTX and adalimumab with MTX.

Professor Iain McInnes joined by Professor Johannes Bijlsma, discusses the changes required to educate the next generation of rheumatologists, highlighting the benefits of online educational courses and the importance of quality amid a plethora of information.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Fleischmann and Professor Takeuchi.

Professor Nash interviews Dr Roland Grenningloh from the EMD Serono Research and Development Institute, about his paper describing the PK modelling of the novel Bruton’s tyrosine kinase (BTK) inhibitor, evobrutinib, in disease models for RA and lupus.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Tanaka and Professor Calabrese.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Josef Smolen and Professor Wenhui Xie, respectively.

Professor Nash interviews Professor Kevin Winthrop from Oregon Health Sciences University, Portland or USA, about his paper investigating pneumococcal and tetanus vaccine responses in patients with RA receiving baricitinib treatment.

Prof McInnes presents the monthly podcast reviewing two papers from Professor Winthrop K and Professor Wollenhaupt J, respectively